| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |